Labcorp Holdings Inc. (LH)
NYSE: LH · Real-Time Price · USD
250.51
+2.66 (1.07%)
Jun 3, 2025, 4:00 PM - Market closed
Labcorp Holdings Employees
Labcorp Holdings had 70,000 employees as of December 31, 2024. The number of employees increased by 3,000 or 4.48% compared to the previous year.
Employees
70,000
Change (1Y)
3,000
Growth (1Y)
4.48%
Revenue / Employee
$188,249
Profits / Employee
$10,440
Market Cap
20.97B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 70,000 | 3,000 | 4.48% |
Dec 31, 2023 | 67,000 | -13,000 | -16.25% |
Dec 31, 2022 | 80,000 | 5,000 | 6.67% |
Dec 31, 2021 | 75,000 | 2,600 | 3.59% |
Dec 31, 2020 | 72,400 | 7,400 | 11.38% |
Dec 31, 2019 | 65,000 | 4,000 | 6.56% |
Dec 31, 2018 | 61,000 | 1,000 | 1.67% |
Dec 31, 2017 | 60,000 | 8,000 | 15.38% |
Dec 31, 2016 | 52,000 | 2,000 | 4.00% |
Dec 31, 2015 | 50,000 | 2,000 | 4.17% |
Dec 31, 2014 | 48,000 | 14,000 | 41.18% |
Dec 31, 2013 | 34,000 | 0 | - |
Dec 31, 2012 | 34,000 | 3,000 | 9.68% |
Dec 31, 2011 | 31,000 | 0 | - |
Dec 31, 2010 | 31,000 | 3,000 | 10.71% |
Dec 31, 2009 | 28,000 | 0 | - |
Dec 31, 2008 | 28,000 | 2,000 | 7.69% |
Dec 31, 2007 | 26,000 | 1,000 | 4.00% |
Dec 31, 2006 | 25,000 | 1,000 | 4.17% |
Dec 31, 2005 | 24,000 | 500 | 2.13% |
Dec 31, 2004 | 23,500 | 500 | 2.17% |
Dec 31, 2003 | 23,000 | -1,000 | -4.17% |
Dec 31, 2002 | 24,000 | 4,400 | 22.45% |
Dec 31, 2001 | 19,600 | 750 | 3.98% |
Dec 31, 2000 | 18,850 | 890 | 4.96% |
Dec 31, 1999 | 17,960 | -840 | -4.47% |
Dec 31, 1998 | 18,800 | 200 | 1.08% |
Dec 31, 1997 | 18,600 | -3,400 | -15.45% |
Dec 31, 1996 | 22,000 | -2,600 | -10.57% |
Dec 31, 1995 | 24,600 | 10,600 | 75.71% |
Dec 31, 1994 | 14,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
LH News
- 1 day ago - ASU, Labcorp, and InStride announce first-of-its-kind diagnostics industry partnership that tackles critical healthcare workforce shortage - GlobeNewsWire
- 4 days ago - Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research - PRNewsWire
- 26 days ago - Labcorp to Webcast Its Annual Meeting of Shareholders May 15 - PRNewsWire
- 5 weeks ago - Labcorp Holdings Inc. (LH) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Labcorp beats quarterly profit estimate on diagnostic test demand - Reuters
- 5 weeks ago - Labcorp Announces 2025 First Quarter Results - PRNewsWire
- 5 weeks ago - Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions - PRNewsWire
- 7 weeks ago - Genetic Screening Testing for the Preventive Health Market, 2025-2035 Analysis - Dominated by Exact Science, Labcorp Genetics, Blueprint Genetics, Ambry Genetics, and Genex Diagnostics - GlobeNewsWire